ArticleAmerican journal of cancer research2025
Resistance patterns of non-small cell lung cancer treated with third-generation epidermal growth factor receptor-tyrosine kinase inhibitors.
Nana Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.